DORVAL RECEIVES LICENCE UNDER EXCISE ACT AND RECEIVES STARTING MATERIALS (English) January 23, 2019 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MQPXF – OTC) (“Matica” or the “Company”) is pleased to announce that the cannabis growing facility in Dorval, Quebec has received rooted starting materials. Pursuant to a site visit of the facility by an agent of the Canada Revenue Agency in late December of 2018, RoyalMax Biotechnology Canada Inc. (“RoyalMax”) is in receipt of a Cannabis Licence under the Excise Act, 2001. This licence, issued on Monday January 21, 2019, was required prior to receiving starting materials. The Company will commence the growing cycle immediately. We anticipate our first harvest in approximately eleven weeks. RoyalMax will begin specializing in one strain with a very high THC concentration. In the coming weeks, other strains will be introduced. About Matica Matica is a multi-faceted, innovative company in the Quebec cannabis space. RoyalMax Biotechnology Canada Inc. ("RoyalMax") was recently granted a cultivation licence by Health Canada for the production facility in Dorval, Quebec. RoyalMax is one of only 11 Licensed Producers in the Province of Quebec. Matica intends to build 1,000,000 square feet of greenhouses on a 181 acre property in the township of Hemmingford, south of Montreal. Matica has entered into an agreement with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company. For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com. On behalf of the Board of Directors MATICA ENTERPRISES INC. Boris Ziger Boris Ziger, CEO & Chairman The Company’s public filings are available for review at www.sedar.com and www.thecse.com. For further information, please contact Remy Scalabrini, Investor Relations, at: Telephone: 1(888) 585-6274 E-mail: info@maticaenterprises.com Website: www.maticaenterprises.com DORVAL REOIT SA LICENCE EN VERTU DE LA LOI SUR L’ACCISE ET REOIT SES CLONES (Franais) 23 janvier, 2019 - Toronto, Ontario - Matica Enterprises Inc. (MMJ – CSE) (39N - Frankfurt) (MQPXF - OTC PINK) («Matica» ou la «Socit») est heureuse d'annoncer que son installation de culture de cannabis situe Dorval, au Qubec, a t prpare et que les clones enracins ont t reus. Suite la visite de notre installation de Dorval, la fin du mois de dcembre 2018, par un agent de l’Agence du Revenu du Canada, RoyalMax Biotechnology Canada Inc. («RoyalMax») a reu sa licence de cannabis en vertu de la Loi de 2001 sur l’accise. Cette licence, qui tait ncessaire avant d’tre en mesure de recevoir les clones, a t octroye lundi le 21 janvier 2019. La socit commencera immdiatement le cycle de culture. Nous estimons effectuer notre premire rcolte dans environ onze semaines. RoyalMax commencera sa production en se spcialisant sur une souche prsentant une trs forte concentration en THC. Dans les prochaines semaines, d’autres souches seront introduites. Propos de Matica Matica est une entreprise innovante aux multiples facettes uvrant dans le secteur du cannabis au Qubec. Sant Canada a rcemment octroy RoyalMax Biotechnology Canada Inc. ("RoyalMax"), une licence de culture pour son installation de production, entirement complte, situe Dorval, au Qubec. RoyalMax est l'un des 11 producteurs licencis de la province de Qubec. Matica a galement l’intention de construire des serres totalisant 1 000 000 de pieds carrs sur un terrain de 181 acres dans le canton de Hemmingford, au sud de Montral. Matica a conclu un accord avec Yunify Natural Technologies, une entreprise qubcoise de recherche et d’innovation en sant et soins personnels. For further information, please contact Remy Scalabrini, Investor Relations, at:
Au nom du conseil d'administration ENTREPRISES MATICA INC. Boris Ziger, PDG et prsident Les rapports de la compagnie sont disponibles pour la consultation sur les sites suivants: www.sedar.com et www.thecse.com. Pour plus d’informations, veuillez contacter Remy Scalabrini, relations aux investisseurs, au: Telephone: 1(888) 585-6274 E-mail: info@maticaenterprises.com Website: www.maticaenterprises.com Disclaimer for Forward-Looking Information Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com. This news release contains statements about the Company’s information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law. Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor. |